These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

685 related items for PubMed ID: 788899

  • 1. Mutagenicity and cytotoxicity of benzo(a)pyrene benzo-ring epoxides.
    Wood AW, Wislocki PG, Chang RL, Levin W, Lu AY, Yagi J, Hernandez O, Herina DM, Conney AH.
    Cancer Res; 1976 Sep; 36(9 pt.1):3358-66. PubMed ID: 788899
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mutagenicity of the bay-region diol-epoxides and other benzo-ring derivatives of dibenzo(a,h)pyrene and dibenzo(a,i)pyrene.
    Wood AW, Chang RL, Levin W, Ryan DE, Thomas PE, Lehr RE, Kumar S, Sardella DJ, Boger E, Yagi H, Sayer JM, Jerina DM, Conney AH.
    Cancer Res; 1981 Jul; 41(7):2589-97. PubMed ID: 7018665
    [Abstract] [Full Text] [Related]

  • 6. Relationship between benzo(a)pyrene-induced DNA base modification and frequency of reverse mutations in mutant strains of Salmonella typhimurium.
    Fahl WE, Scarpelli DG, Gill K.
    Cancer Res; 1981 Sep; 41(9 Pt 1):3400-6. PubMed ID: 6266655
    [Abstract] [Full Text] [Related]

  • 7. Bacterial and mammalian cell mutagenicity of four optically active bay-region 3,4-diol-1,2-epoxides and other derivatives of the nitrogen heterocycle dibenz[c,h]acridine.
    Wood AW, Chang RL, Levin W, Kumar S, Shirai N, Jerina DM, Lehr RE, Conney AH.
    Cancer Res; 1986 Jun; 46(6):2760-6. PubMed ID: 3516386
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mutagenicity of dihydrodiols and diol epoxides of dibenz[a, h]acridine in bacterial and mammalian cells.
    Wood AW, Chang RL, Katz M, Conney AH, Jerina DM, Sikka HC, Levin W, Kumar S.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):6981-4. PubMed ID: 2684405
    [Abstract] [Full Text] [Related]

  • 10. Mutagenicity of isomeric diol-epoxides of benzo[a]pyrene and benz[a]anthracene in S. typhimurium TA98 and TA100 and in V79 Chinese hamster cells.
    Malaveille C, Kuroki T, Sims P, Grover PL, Bartsch H.
    Mutat Res; 1977 Sep 15; 44(3):313-26. PubMed ID: 333280
    [Abstract] [Full Text] [Related]

  • 11. Mutagenicity of the enantiomers of the diastereomeric bay-region benz(a)anthracene 3,4-diol-1,2-epoxides in bacterial and mammalian cells.
    Wood AW, Chang RL, Levin W, Yagi H, Thakker DR, van Bladeren PJ, Jerina DM, Conney AH.
    Cancer Res; 1983 Dec 15; 43(12 Pt 1):5821-5. PubMed ID: 6357432
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of the mutagenicity of bay-region diol epoxides of polycyclic aromatic hydrocarbons by naturally occurring plant phenols: exceptional activity of ellagic acid.
    Wood AW, Huang MT, Chang RL, Newmark HL, Lehr RE, Yagi H, Sayer JM, Jerina DM, Conney AH.
    Proc Natl Acad Sci U S A; 1982 Sep 15; 79(18):5513-7. PubMed ID: 6752950
    [Abstract] [Full Text] [Related]

  • 13. Arene imines, a new class of exceptionally potent mutagens in bacterial and mammalian cells.
    Glatt H, Ludewig G, Platt KL, Waechter F, Yona I, Ben-Shoshan S, Jerushalmy P, Blum J, Oesch F.
    Cancer Res; 1985 Jun 15; 45(6):2600-7. PubMed ID: 3921247
    [Abstract] [Full Text] [Related]

  • 14. Mutagenicity of the enantiomers of the diastereomeric bay-region benzo(c)phenanthrene 3,4-diol-1,2-epoxides in bacterial and mammalian cells.
    Wood AW, Chang RL, Levin W, Thakker DR, Yagi H, Sayer JM, Jerina DM, Conney AH.
    Cancer Res; 1984 Jun 15; 44(6):2320-4. PubMed ID: 6372992
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the tumor-initiating activities of benzo(a)pyrene arene oxides and diol-epoxides.
    Slaga TJ, Bracken WM, Viaje A, Levin W, Yagi H, Jerina DM, Conney AH.
    Cancer Res; 1977 Nov 15; 37(11):4130-3. PubMed ID: 908047
    [Abstract] [Full Text] [Related]

  • 16. Epidermal hyperplasia after topical application of benzo (a) pyrene, benzo (a) pyrene diol epoxides, and other metabolites.
    Bresnick E, McDonald TF, Yagi H, Jerina DM, Levin W, Wood AW, Conney AH.
    Cancer Res; 1977 Apr 15; 37(4):984-90. PubMed ID: 844052
    [Abstract] [Full Text] [Related]

  • 17. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
    Glatt H, Seidel A, Bochnitschek W, Marquardt H, Marquardt H, Hodgson RM, Grover PL, Oesch F.
    Cancer Res; 1986 Sep 15; 46(9):4556-65. PubMed ID: 3524815
    [Abstract] [Full Text] [Related]

  • 18. Carcinogenicity of benzo-ring derivatives of benzo(a)pyrene on mouse skin.
    Levin W, Wood AW, Wislocki PG, Kapitulnik J, Yagi H, Jerina DM, Conney AH.
    Cancer Res; 1977 Sep 15; 37(9):3356-61. PubMed ID: 884679
    [Abstract] [Full Text] [Related]

  • 19. Relationships of quantum mechanical calculations, relative mutagenicity of benzo[a]anthracene diol epoxides, and "bay region" concept of aromatic hydrocarbon carcinogenicity.
    Lehr RE, Jerina DM.
    J Toxicol Environ Health; 1977 Jul 15; 2(6):1259-65. PubMed ID: 328916
    [Abstract] [Full Text] [Related]

  • 20. Species-specific enhancement by 7,8-benzoflavone of hepatic microsomal metabolism of benzo[e]pyrene 9,10-dihydrodiol to bay-region diol epoxides.
    Thakker DR, Levin W, Buening M, Yagi H, Lehr RE, Wood AW, Conney AH, Jerina DM.
    Cancer Res; 1981 Apr 15; 41(4):1389-96. PubMed ID: 7194138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.